Leukocyte Telomeric G-Tail Length Shortening Is Associated with Esophageal Cancer Recurrence

Jiayan Han,Soichiro Hayashi,Ryou-u Takahashi,Ryosuke Hirohata,Tomoaki Kurokawa,Mizuki Tashiro,Yuki Yamamoto,Morihito Okada,Hidetoshi Tahara
DOI: https://doi.org/10.3390/jcm11247385
IF: 3.9
2022-12-12
Journal of Clinical Medicine
Abstract:Despite significant advances in therapeutics for esophageal cancer (ESC) in the past decade, it remains the sixth most fatal malignancy, with a poor 5-year survival rate (approximately 10%). There is an urgent need to improve the timely diagnosis to aid the prediction of the therapeutic response and prognosis of patients with ESC. The telomeric G-tail plays an important role in the chromosome protection. However, aging and age-related diseases lead to its shortening. Therefore, the G-tail length has been proposed as a novel potential biomarker. In the present study, to examine the possibility of G-tail shortening in patients with ESC, we measured the leukocyte telomere length (LTL) and the G-tail length using a hybridization protection assay in 147 patients with ESC and 170 age-matched healthy controls. We found that the G-tail length in patients with ESC was shorter than that in the healthy controls (p = 0.02), while the LTL shortening was not correlated with the ESC incidence and recurrence. Our results suggest that the G-tail length reflects the physiological status of patients with ESC and is a promising biomarker for the diagnosis and prognosis of ESC.
medicine, general & internal
What problem does this paper attempt to address?